Nonoyama T., Fullerton F., Reznik G., Bucci T
the methods comprise the step of administering to the patient an amount of one or more hepatocyte growth factor mimics sufficient to reverse, ameliorate or slow progression of the at least one symptom
Clair, C., Cohen, M
To get a drug FDA approved, a company must conduct phase 1, 2 and 3 clinical trials proving safety and efficacy of the compound through a laborious, multi year and extremely costly process
We propose ALCAR as a new possible repurposed agent for cancer prevention and interception, similar to aspirin, metformin or beta-blockers
The peptide activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway, promoting cell survival and inhibiting apoptosis in stressed cells